WILLIAM L CIEPLINSKI

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology GOSHEN, NY NPI 1306825815

General Payments — all program years on this page

$909.90

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 46
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $410.63 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $410.6321

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $33.303
2019 $110.563
2020 $33.092
2021 $134.968
2023 $187.369
2024 $410.6321

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086780939 Novartis Pharmaceuticals Corporation $22.75 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089409478 Daiichi Sankyo Inc. $19.75 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089409480 Daiichi Sankyo Inc. $22.92 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101116730 Celgene Corporation $19.77 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101116738 Celgene Corporation $18.99 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101116744 Celgene Corporation $13.49 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101352852 E.R. Squibb & Sons, L.L.C. $18.15 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101352870 E.R. Squibb & Sons, L.L.C. $21.69 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101352874 E.R. Squibb & Sons, L.L.C. $17.21 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101352886 E.R. Squibb & Sons, L.L.C. $18.92 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101352912 E.R. Squibb & Sons, L.L.C. $21.67 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103474259 ABBVIE INC. $19.92 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103474261 ABBVIE INC. $20.06 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104589752 AstraZeneca Pharmaceuticals LP $21.78 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130969992 PFIZER INC. $14.98 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130990376 ARRAY BIOPHARMA INC $25.45 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135478828 Lilly USA, LLC $17.05 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141221430 Incyte Corporation $20.69 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141800904 Merck Sharp & Dohme LLC $19.93 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141800906 Merck Sharp & Dohme LLC $20.73 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144525972 Indivior Inc. $14.73 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.